MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistanceAmy Farrell, Rosalie C. Sears, Jason M. Link et al.|Nature Communications|2017Cited by 159
Abstract 2480: RE1-silencing transcription factor (REST) controls neuroendocrine gene programs in pancreatic ductal adenocarcinomaRosalie C. Sears, Meghan M. Joly, Brittany L. Allen-Petersen et al.|Cancer Research|2021Cited by 0
Abstract 787: RE1-silencing transcription factor (REST) controls neuroendocrine gene programs in pancreatic ductal adenocarcinomaRosalie C. Sears, Meghan M. Joly, Brittany L. Allen-Petersen et al.|Cancer Research|2022Cited by 0
Abstract A061: A novel genetically engineered mouse model of Myc-driven pancreatic cancer recapitulates phenotypic heterogeneity, metastasis, and therapy resistance seen in clinical populationsIsabel A. English, Rosalie C. Sears, Patrick J. Worth et al.|Cancer Research|2024Cited by 0